Publikation:

Impurity-free amorphous calcium carbonate, a preferential material for pharmaceutic and medical applications

Lade...
Vorschaubild

Dateien

Avaro_2-kkbxn9mxwgln4.pdf
Avaro_2-kkbxn9mxwgln4.pdfGröße: 582.26 KBDownloads: 330

Datum

2019

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

ArXiv-ID

Internationale Patentnummer

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Open Access Hybrid
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

European Journal of Mineralogy. 2019, 31(2), pp. 231-236. ISSN 0935-1221. eISSN 1617-4011. Available under: doi: 10.1127/ejm/2019/0031-2831

Zusammenfassung

Biomedical applications of calcium carbonate minerals have been receiving an increasing amount of attention. With a simple chemical composition, low production cost, and ease to produce in large quantities, this non-toxic (bio)mineral has been used preferentially in the pharmaceutical industry as a diluent, bulking or coating agent. Recently, novel products have been developed and amorphous calcium carbonate was successfully used as a hybrid carrier for drugs, proteins and genes. It is obvious that any impurities might have adverse effects in any of the aforementioned applications. However, the synthesis of impurity-free amorphous calcium carbonate often proves to be challenging due to its instability and rapid transformation to crystalline phases. Herein, we describe a novel, simple and scalable protocol for the synthesis of such impurity-free amorphous calcium carbonate nanoparticles that is potentially invaluable for critical health applications, improving the applicability of amorphous calcium carbonates in pharmaceutical and medical domains.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
540 Chemie

Schlagwörter

amorphous calcium carbonate, nanoparticles, impurity-free, synthesis, drug delivery

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690AVARO, Jonathan Thomas, Cristina RUIZ AGUDO, Eliane LANDWEHR, Karin HAUSER, Denis GEBAUER, 2019. Impurity-free amorphous calcium carbonate, a preferential material for pharmaceutic and medical applications. In: European Journal of Mineralogy. 2019, 31(2), pp. 231-236. ISSN 0935-1221. eISSN 1617-4011. Available under: doi: 10.1127/ejm/2019/0031-2831
BibTex
@article{Avaro2019-06-07Impur-45103,
  year={2019},
  doi={10.1127/ejm/2019/0031-2831},
  title={Impurity-free amorphous calcium carbonate, a preferential material for pharmaceutic and medical applications},
  url={https://pubs.geoscienceworld.org/eurjmin/article-abstract/568487/impurity-free-amorphous-calcium-carbonate-a?redirectedFrom=fulltext},
  number={2},
  volume={31},
  issn={0935-1221},
  journal={European Journal of Mineralogy},
  pages={231--236},
  author={Avaro, Jonathan Thomas and Ruiz Agudo, Cristina and Landwehr, Eliane and Hauser, Karin and Gebauer, Denis}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/45103">
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/52"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>Gebauer, Denis</dc:contributor>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/45103/1/Avaro_2-kkbxn9mxwgln4.pdf"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Hauser, Karin</dc:creator>
    <dc:creator>Avaro, Jonathan Thomas</dc:creator>
    <dc:language>eng</dc:language>
    <dc:rights>terms-of-use</dc:rights>
    <dcterms:abstract xml:lang="eng">Biomedical applications of calcium carbonate minerals have been receiving an increasing amount of attention. With a simple chemical composition, low production cost, and ease to produce in large quantities, this non-toxic (bio)mineral has been used preferentially in the pharmaceutical industry as a diluent, bulking or coating agent. Recently, novel products have been developed and amorphous calcium carbonate was successfully used as a hybrid carrier for drugs, proteins and genes. It is obvious that any impurities might have adverse effects in any of the aforementioned applications. However, the synthesis of impurity-free amorphous calcium carbonate often proves to be challenging due to its instability and rapid transformation to crystalline phases. Herein, we describe a novel, simple and scalable protocol for the synthesis of such impurity-free amorphous calcium carbonate nanoparticles that is potentially invaluable for critical health applications, improving the applicability of amorphous calcium carbonates in pharmaceutical and medical domains.</dcterms:abstract>
    <dc:creator>Landwehr, Eliane</dc:creator>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <dcterms:issued>2019-06-07</dcterms:issued>
    <dc:contributor>Ruiz Agudo, Cristina</dc:contributor>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/45103"/>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-19T14:38:34Z</dcterms:available>
    <dc:creator>Ruiz Agudo, Cristina</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/45103/1/Avaro_2-kkbxn9mxwgln4.pdf"/>
    <dc:contributor>Hauser, Karin</dc:contributor>
    <dcterms:title>Impurity-free amorphous calcium carbonate, a preferential material for pharmaceutic and medical applications</dcterms:title>
    <dc:creator>Gebauer, Denis</dc:creator>
    <dc:contributor>Landwehr, Eliane</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/52"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-19T14:38:34Z</dc:date>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:contributor>Avaro, Jonathan Thomas</dc:contributor>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Ja
Diese Publikation teilen